Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study comparing the safety and efficacy of BGB-16673 versus Pirtobrutinib in adults with relapsed or refractory c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• BGB-16673
• Pirtobrutinib (pirtobrutinib)

Snippet

Sponsor: BeOne Medicines | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | Status: RECRUITING